mRNA Based Vaccines


Viral Vectors


From Diversity to Protection


SARS-COV2 Spread and Evolution to Instruct Pan- Vaccine Development Strategies


Coffee Break


Epidemiological and Evolutionary Considerations of SARS-CoV-2 Vaccine Administration Schemes


Short Talk: INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T Cell Activity Against Global SARS-CoV-2 Variants


Short Talk: Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates


Planning for Correlates for Phase 3 Studies: Lessons from COVID


Pandemic Preparedness: Lessons from COVID